3 January 2012 - Geneva, Switzerland - Eli Lilly and Company has appointed Dr Evan Lee as vice president of global health programmes and access. Lee starts his role today and will be based in Geneva.
Dr Lee will oversee Lilly’s international aid unit in Geneva and have accountability for representing Lilly with key global health stakeholders in Geneva and around the world. He will also be responsible for Lilly’s global health programs, including its multidrug-resistant tuberculosis (MDR-TB) and non-communicable diseases initiatives, as well as efforts related to access to medicines.
The Lilly MDR-TB Partnership and The Lilly NCD Partnership are Lilly’s two signature corporate responsibility programs focused on identifying new ways to increase treatment access and improve health outcomes for people in economically developing countries.
Dr Lee most recently served as a senior policy officer for the Foundation for Innovative New Diagnostics (FIND) in Geneva, where he led numerous international initiatives aimed at reducing the burden of TB and malaria. His accomplishments included the launch of Expand-TB, a project funded by UNITAID, which helped introduce new TB diagnostics in 27 countries. Previously he held positions at Management Sciences for Health, Europe, Médecins Sans Frontières and as a TB program coordinator in Kenya.